Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Sat, Jan 31, 2026
[Archive]
Volume 17, Issue 1 (Winter 2026)
Caspian J Intern Med 2026, 17(1): 211-212 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nazari Taloki Z. Sodium-glucose transport 2 inhibitors: Practical management of the venetoclax-induced adverse events. Caspian J Intern Med 2026; 17 (1) :211-212
URL: http://caspjim.com/article-1-4731-en.html
URL: http://caspjim.com/article-1-4731-en.html
Sodium-glucose transport 2 inhibitors: Practical management of the venetoclax-induced adverse events
Department of Clinical Pharmacy, School of Pharmacy, Babol University of Medical Sciences, Babol, Iran & Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran , zahra_nazari_taloki@yahoo.com
Abstract: (47 Views)
Sodium-glucose transport 2 inhibitors: Practical management of the venetoclax-induced adverse events
Keywords: SGLT2Is, Venetoclax, Adverse events, quality of life, Hyperglycemia, Hyperuricemia, Neutropenia, Anemia
Policy Brief: Letter to Editor |
Subject:
Hematology
Received: 2025/03/28 | Accepted: 2025/07/13 | Published: 2026/01/1
Received: 2025/03/28 | Accepted: 2025/07/13 | Published: 2026/01/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
